Australia's Resonance Health rises on entering U.S. medical reimbursement framework

Resonance Health

07/02/2022 02:25

** Shares of Resonance Health Ltd  RHT.AX  climb as much as
16.7% to A$0.175, post their biggest intraday percentage gain
since Jan. 12
    ** Medical imaging software developer says Liversmart, which
measures iron and fat concentration in liver through MRI
technology, eligible for two new U.S. (category III) current
procedural terminology (CPT) codes  urn:newsml:reuters.com:*:nASX7VH9zq
    ** Says CPT codes describe medical services for
reimbursement by government and private payers 
    ** Adds LiverSmart's eligibility marks co's first formal
step into the U.S. national reimbursement coding framework
    ** Shares hit their highest since Jan. 21
    ** As of last close, stock up 7.1% this year

 (Reporting by Himanshi Akhand in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))